Asia pacific nuclear medicine radiopharmaceuticals stable isotopes

It has major applications in research, pharmaceuticals, diagnostic and therapy, and the industrial sector. The geographical regions covered in this report are North America U.

Signup for Free Webinar

For more information please visit- https: This paves the way for novel isotopes such as Tl, F, and Rb to capitalize on opportunities in the growing diagnostics market. Alpha radiation accounted largest and is the fastest growing segment market with projected high double digit CAGR from to due to increase in market penetration of Ra based product and regulatory approval FDA and CE also availability due to region specific licenses granted by Bayer.

Your Shopping Cart Is Empty

Hospitals market accounted largest share in and is the fastest growing market with projected high single digit CAGR from to due to ready availability of cyclotrons for generation of isotopes and presence of trained technicians who can handle radioisotopes. Analysis of the regulatory bodies guiding the manufacturers, ongoing clinical trials and supply chain of the Nuclear Medicine global market.

Japan accounted for the largest market share of the Asia-Pacific nuclear medicine market, followed by China in With fact-based insights and accurate market forecasts, we enable our clients to understand and respond to the market dynamics with an edge over their competitors.

The research report meticulously analyses the radiopharmaceutical market on the basis of following categories.

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals to top £800 Million by 2017

The total number of PET institutes in Japan has increased around times in the last 10 years. Chief executives and VPs of leading corporations specific to industry Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders KOLs Analyst tools and models AMR has developed set of analyst tools and data models to supplement and expedite the analysis process.

Global Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Outlook: 2013-2018

Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. SPECT is majorly used in cardiology related diagnosis. Cardiology market accounted largest share and is the fastest growing market with projected high single digit CAGR from to due to increase in number of cardiac imaging procedures using Tcm.

Japan is the dominant Market for Diagnostic Radioisotopes with almost 40 percent share and has around 1, gamma cameras, installed in about 1, institutions; PET diagnosis has increased dramatically after They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

The stable isotopes market is dominated by carbon C ,deuterium D2oxygen Oand nitrogen N Request Customization Isotope analysis is the identity of isotopic signature, the distribution of certain strong isotopes and chemical elements inside chemical compounds.

Identification and analysis of the Nuclear Medicine global market segments by modality, products, by application, end-user and geography.

Nuclear Medicine/Radiopharmaceuticals Global Market Estimated to be Worth $9,368 Million by 2024

Stable isotopes are precursors used in production of radioisotopes and market is segmented into carbon CDeuterium D-2Oxygen ONitrogen NSulphur S and others. Our clients include leading businesses, investment banks, researchers and government agencies.

Identification and analysis of the Stable Isotope global market segments by isotope, by application and geography.Presentation Description [ Report Pages] The Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market have been segmented according to the type of isotope, and applications.

Similar to the global nuclear medicine market, the Asia-Pacific region is also reducing its dependency on nuclear reactors by introducing hospital-based cyclotron facilities.

This paves the way for novel isotopes such as Tl, F, and Rb to capitalise on opportunities in the growing diagnostics market.

The global radioisotopes & enriched stable isotopes market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan. Essay about Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Forecast to This report studies the Asia - Pacific nuclear medicine market over the forecast period of Asia Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, Radiopharmaceuticals in neurological applications such as Alzheimer’s disease, Parkinson’s disease, and dementia are boosting the growth of the Asia-Pacific nuclear medicine market.

Upcoming radioisotopes such as Ra (Alpharadin) and Ga possess huge potential for clinical applications.

Download
Asia pacific nuclear medicine radiopharmaceuticals stable isotopes
Rated 5/5 based on 87 review